IN2012DN06061A - - Google Patents

Download PDF

Info

Publication number
IN2012DN06061A
IN2012DN06061A IN6061DEN2012A IN2012DN06061A IN 2012DN06061 A IN2012DN06061 A IN 2012DN06061A IN 6061DEN2012 A IN6061DEN2012 A IN 6061DEN2012A IN 2012DN06061 A IN2012DN06061 A IN 2012DN06061A
Authority
IN
India
Prior art keywords
pyrazol
thiazole
disorders
inhibitors
diseases
Prior art date
Application number
Other languages
English (en)
Inventor
Nicole Cathleen Goodwin
David Brent Rawlins
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Publication of IN2012DN06061A publication Critical patent/IN2012DN06061A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN6061DEN2012 2010-01-22 2011-01-21 IN2012DN06061A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29739710P 2010-01-22 2010-01-22
PCT/US2011/021970 WO2011091204A1 (fr) 2010-01-22 2011-01-21 Composés à base de 5-(1h-pyrazol-5-yl)thiazole pour le traitement de maladies et troubles de l'œil

Publications (1)

Publication Number Publication Date
IN2012DN06061A true IN2012DN06061A (fr) 2015-09-18

Family

ID=43760212

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6061DEN2012 IN2012DN06061A (fr) 2010-01-22 2011-01-21

Country Status (8)

Country Link
US (1) US20130059896A1 (fr)
EP (1) EP2525794A1 (fr)
JP (1) JP2013518048A (fr)
CN (1) CN102711758A (fr)
AU (1) AU2011207280A1 (fr)
CA (1) CA2786730A1 (fr)
IN (1) IN2012DN06061A (fr)
WO (1) WO2011091204A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130143927A1 (en) * 2011-06-10 2013-06-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
US20120316182A1 (en) 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
US9856240B2 (en) 2011-10-19 2018-01-02 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2018055097A1 (fr) 2016-09-23 2018-03-29 Cellipse Inhibiteurs de kinase lim, composition pharmaceutique et procédé d'utilisation dans des maladies induites par limk
CN115197166B (zh) * 2022-07-11 2024-07-02 安徽英瑞骐生物科技有限公司 一种4-甲基-2-肼基苯并噻唑的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
EP1020447A4 (fr) * 1997-09-11 2000-11-15 Nissan Chemical Ind Ltd Composes a base de pyrazole et agent de lutte contre les maladies vegetales
WO2002099140A1 (fr) 2001-06-05 2002-12-12 Exelixis, Inc. Glra utiles en tant que modificateurs de la voie de p53 et methodes d'utilisation
US20050008643A1 (en) 2001-06-27 2005-01-13 Ora Bernard Diagnostic methods and agents
WO2004047868A1 (fr) 2002-11-27 2004-06-10 Santen Pharmaceutical Co., Ltd. Traitement du glaucome contenant comme principe actif un compose inhibant la lim kinase
TWI336257B (en) 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
MX373178B (es) 2007-04-03 2020-04-22 Fmc Corp Star Fungicidas de benceno sustituido.
AU2008285388B2 (en) 2007-08-08 2013-09-19 Lexicon Pharmaceuticals, Inc. (7h-pyrrolo [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation
EA019488B1 (ru) 2008-04-21 2014-04-30 Лексикон Фармасьютикалз, Инк. Ингибиторы limk2 и способы их применения

Also Published As

Publication number Publication date
US20130059896A1 (en) 2013-03-07
JP2013518048A (ja) 2013-05-20
CA2786730A1 (fr) 2011-07-28
WO2011091204A1 (fr) 2011-07-28
EP2525794A1 (fr) 2012-11-28
CN102711758A (zh) 2012-10-03
AU2011207280A1 (en) 2012-07-19

Similar Documents

Publication Publication Date Title
WO2014028600A3 (fr) Composés 3-aminocycloalkyl utilisés en tant qu'inhibiteurs de rorgammat et utilisations de ceux-ci
TN2013000348A1 (en) Compounds and compositions as trk inhibitors
UA116774C2 (uk) Інгібітори серин/треонінкінази
PH12014500468A1 (en) Heterocyclic compounds and uses thereof
WO2014028591A3 (fr) Composés indazole et indole n-alkylés utilisés en tant qu'inhibiteurs de rorgammat et utilisations de ceux-ci
HK1198443A1 (en) Heterocyclic compounds and uses thereof
MX2015012431A (es) Pirrol amida como inhibidores.
WO2014031928A3 (fr) Modulateurs hétérocycliques de l'activité du facteur hif utilisés pour le traitement de maladies
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
EA023222B8 (ru) Пиразолилхиноксалиновые ингибиторы киназы
MX2014012695A (es) Derivados de isoindolona.
HK1207069A1 (en) Heterocyclic compounds and uses thereof
WO2014179564A8 (fr) Inhibiteurs du ror-gamma à base de thiazolopyrrolidine
AU2012214029A8 (en) Rorgammat inhibitors
MX353806B (es) Quinolinas como moduladores de cinasas del receptor del factor de crecimiento de fibroblasto (fgfr).
MX370906B (es) Inhibidores de serina/treonina cinasa.
WO2012013282A8 (fr) Carboxamides azahétérocycliques bicycliques en tant qu'inhibiteurs de la kinase p70s6k
WO2014031933A3 (fr) Modulateurs hétérocycliques de l'activité du facteur hif utilisés pour le traitement de maladies
WO2012048129A3 (fr) Inhibiteurs de kinase de type polo
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
IN2015DN01151A (fr)
WO2014031936A3 (fr) Modulateurs hétérocycliques de l'activité du facteur hif utilisés pour le traitement de maladies
MX2012001134A (es) Composiciones y metodos para inhibicion de la via jak.
WO2011150201A3 (fr) Composés azolylamide et leurs procédés d'utilisation
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний